Michael Thomas Heffernan - Net Worth and Insider Trading

Over the past 18 months, Michael Thomas Heffernan made 3 insider transaction in Collegium Pharmaceutical Inc (COLL) with a net sale of 298,612. Other recent insider transactions involving Collegium Pharmaceutical Inc (COLL) include a net sale of 164,703 shares made by Joseph Ciaffoni , a net sale of 60,700 shares made by Shirley R. Kuhlmann , and a net sale of 34,086 shares made by Scott Dreyer .

In summary, during the past 3 months, insiders sold 78,397 shares of Collegium Pharmaceutical Inc (COLL) in total and bought 0 shares, with a net sale of 78,397 shares. During the past 18 months, 562,451 shares of Collegium Pharmaceutical Inc (COLL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 562,451 shares.

Collegium Pharmaceutical Inc (COLL)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Michael Thomas Heffernan made no insider transaction in Trevi Therapeutics Inc (TRVI). Other recent insider transactions involving Trevi Therapeutics Inc (TRVI) include a net sale of 1,000,000 shares made by Tpg Gp A, Llc , a net sale of 9,366 shares made by Lisa Delfini , and a net purchase of 3,580,526 shares made by Scott D Sandell .

In summary, during the past 3 months, insiders sold 9,366 shares of Trevi Therapeutics Inc (TRVI) in total and bought 0 shares, with a net sale of 9,366 shares. During the past 18 months, 1,009,366 shares of Trevi Therapeutics Inc (TRVI) were sold and 30,326,838 shares were bought by its insiders, resulting in a net purchase of 29,317,472 shares.

Trevi Therapeutics Inc (TRVI)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Michael Thomas Heffernan made no insider transaction in Akebia Therapeutics Inc (AKBA). Other recent insider transactions involving Akebia Therapeutics Inc (AKBA) include a net sale of 22,809 shares made by Steven Keith Burke , a net sale of 130,500 shares made by John P. Butler , and a net sale of 30,502 shares made by Michel Dahan .

In summary, during the past 3 months, insiders sold 217,124 shares of Akebia Therapeutics Inc (AKBA) in total and bought 0 shares, with a net sale of 217,124 shares. During the past 18 months, 228,671 shares of Akebia Therapeutics Inc (AKBA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 228,671 shares.

Akebia Therapeutics Inc (AKBA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Michael Thomas Heffernan made no insider transaction in Biohaven Pharmaceutical Holding Co Ltd (BHVN). Other recent insider transactions involving Biohaven Pharmaceutical Holding Co Ltd (BHVN) include a net sale of 15,490 shares made by George C. Clark , a net sale of 62,265 shares made by Declan Doogan , and a net purchase of 38,000 shares made by Gregory Bailey .

In summary, during the past 3 months, insiders sold 0 shares of Biohaven Pharmaceutical Holding Co Ltd (BHVN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 153,613 shares of Biohaven Pharmaceutical Holding Co Ltd (BHVN) were sold and 43,000 shares were bought by its insiders, resulting in a net sale of 110,613 shares.

Biohaven Pharmaceutical Holding Co Ltd (BHVN)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Keryx Biopharmaceuticals Inc (KERX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Keryx Biopharmaceuticals Inc (KERX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Keryx Biopharmaceuticals Inc (KERX)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Ocata Therapeutics Inc (OCAT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Ocata Therapeutics Inc (OCAT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Ocata Therapeutics Inc (OCAT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Michael Thomas Heffernan made no insider transaction in Synlogic Inc (SYBX). Other recent insider transactions involving Synlogic Inc (SYBX) include a net purchase of 9,500 shares made by Michael Vangsted Jensen , a net sale of 8,894 shares made by Aoife Brennan , and a net sale of 2,650 shares made by Antoine Awad .

In summary, during the past 3 months, insiders sold 0 shares of Synlogic Inc (SYBX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 11,544 shares of Synlogic Inc (SYBX) were sold and 9,500 shares were bought by its insiders, resulting in a net sale of 2,044 shares.

Synlogic Inc (SYBX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Michael Thomas Heffernan made no insider transaction in Biohaven Ltd (BHVN). Other recent insider transactions involving Biohaven Ltd (BHVN) include a net purchase of 1,021,110 shares made by Vlad Coric , a net purchase of 7,609,819 shares made by John W Childs , and a net purchase of 200,000 shares made by Gregory Bailey .

In summary, during the past 3 months, insiders sold 0 shares of Biohaven Ltd (BHVN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Biohaven Ltd (BHVN) were sold and 8,983,309 shares were bought by its insiders, resulting in a net purchase of 8,983,309 shares.

Biohaven Ltd (BHVN)'s detailed insider trading history can be found in Insider Trading Tracker table.